Genome Editing in a Wide Area of the Brain Using Dendrimer-Based Ternary Polyplexes of Cas9 Ribonucleoprotein
- 21 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (19) , 21386-21397
Abstract
Preassembled Cas9/single-guide RNA complex (Cas9 ribonucleoprotein; Cas9 RNP) induces genome editing efficiently, with small off-target effects compared with the conventional techniques, such as plasmid DNA and mRNA systems. However, penetration of Cas9 RNP through the cell membrane is low. In particular, the incorporation of Cas9 RNP into neurons and the brain is challenging. In the present study, we have reported the use of a dendrimer (generation 3; G3)/glucuronylglucosyl-β-cyclodextrin conjugate (GUG-β-CDE (G3)) as a carrier of Cas9 RNP and evaluate genome editing activity in the neuron and the brain. Cas9 RNP ternary complex with GUG-β-CDE (G3) was prepared by only mixing the components. The resulting complex exhibited higher genome editing activity than the complex with dendrimer (G3), LipofectamineTM 3000 or LipofectamineTM CRISPRMAXTM in SH-SY5Y cells, a human neuroblastoma cell line. In addition, GUG-β-CDE (G3) enhanced the genome editing activity of Cas9 RNP in the whole mouse brain after a single intraventricular administration. Thus, GUG-β-CDE (G3) is a useful Cas9 RNP carrier can induce genome editing in the neuron and brain.Keywords
This publication has 65 references indexed in Scilit:
- Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet Neurology, 2017
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Huntingtonʼs diseaseCurrent Opinion in Neurology, 2012
- Niemann-Pick disease type COrphanet Journal of Rare Diseases, 2010
- Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and FunctionNeuron, 2008
- GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspectsMolecular Genetics and Metabolism, 2008
- Lysosomal storage disordersBritish Journal of Haematology, 2005
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- The molecular basis of lysosomal storage diseases and their treatmentBiochemical Society Transactions, 2000
- Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2Nature Genetics, 1999